Tuesday, June 21, 2016
- 12:30pm-2:00pm
-
Effect of zonisamide on post-traumatic Holmes’ tremor
Tremor · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Effects of Arachidonyl-2′-chloroethylamide (ACEA), a selective CB1 receptor agonist, in MPTP mouse model of Parkinson’s disease
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Efficacy and safety of a L-dopa delivery and monitoring medical device
Technology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Elevated SNCA expression in CD45+ peripheral blood cells in patients with dementia with Lewy bodies
Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Elucidating mechanisms of endogenous disease protection resulting in reduced penetrance in PINK1 deficiency
Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Endoscopically-documented pharyngeal dystonia due to neuroleptic use without response to alcohol
Drug-induced movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Enteric neurons reveal substantial in vivo mitochondrial changes in Parkinson’s disease
- 12:30pm-2:00pm
-
Epigenome-wide association study of Parkinson’s disease
- 12:30pm-2:00pm
-
ESCRT-0 dysfunction compromises autophagic degradation of protein aggregates and facilitates ER stress-mediated neurodegeneration via apoptotic and necroptotic pathways
Pathophysiology (other movement disorders) · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Essential tremor: Characterization according to their phenotypes and their association with Parkinsonian signs
Tremor · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 48
- Next Page»